1. Home
  2. JFIN vs LENZ Comparison

JFIN vs LENZ Comparison

Compare JFIN & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

JFIN

Jiayin Group Inc.

HOLD

Current Price

$4.89

Market Cap

247.1M

Sector

Finance

ML Signal

HOLD

Logo LENZ Therapeutics Inc.

LENZ

LENZ Therapeutics Inc.

HOLD

Current Price

$9.26

Market Cap

278.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JFIN
LENZ
Founded
2011
2019
Country
China
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
247.1M
278.4M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
JFIN
LENZ
Price
$4.89
$9.26
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$44.00
AVG Volume (30 Days)
40.7K
664.0K
Earning Date
06-03-2026
05-06-2026
Dividend Yield
17.47%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$19,088,000.00
Revenue This Year
N/A
$50.42
Revenue Next Year
N/A
$197.16
P/E Ratio
$1.35
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.70
$8.25
52 Week High
$18.70
$50.19

Technical Indicators

Market Signals
Indicator
JFIN
LENZ
Relative Strength Index (RSI) 53.01 44.15
Support Level $3.70 $8.99
Resistance Level $5.00 $10.34
Average True Range (ATR) 0.21 0.59
MACD 0.09 0.04
Stochastic Oscillator 83.19 31.52

Price Performance

Historical Comparison
JFIN
LENZ

About JFIN Jiayin Group Inc.

Jiayin Group Inc is China's technology service group. It is an enterprise engaged in technological innovation services. It is committed to using big data, cloud computing, artificial intelligence and other technologies to connect consumers and financial institutions in consumption scenarios so that every user can enjoy efficient and convenient technology services. The company has engraved technological innovation into the company's development genes since its establishment, adheres to the dual drive of digital plus technology, and focuses on building a cloud service platform and intelligent risk control system with big data drive as the core concept.

About LENZ LENZ Therapeutics Inc.

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.

Share on Social Networks: